413 related articles for article (PubMed ID: 30572726)
1. Nanotheranostics, a future remedy of neurological disorders.
Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
3. Towards tailored management of malignant brain tumors with nanotheranostics.
Aparicio-Blanco J; Torres-Suárez AI
Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
[TBL] [Abstract][Full Text] [Related]
4. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
5. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
Bertalan F; László B; Attila V
Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
[TBL] [Abstract][Full Text] [Related]
6. Theranostical application of nanomedicine for treating central nervous system disorders.
Ran W; Xue X
Sci China Life Sci; 2018 Apr; 61(4):392-399. PubMed ID: 29675554
[TBL] [Abstract][Full Text] [Related]
7. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Lammers T; Kiessling F; Hennink WE; Storm G
Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
[TBL] [Abstract][Full Text] [Related]
8. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine based nanoparticles for neurological disorders.
Sriramoju B; Kanwar RK; Kanwar JR
Curr Med Chem; 2014; 21(36):4154-68. PubMed ID: 25039778
[TBL] [Abstract][Full Text] [Related]
10. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
12. Magnetic hybrid nanovesicles for the precise diagnosis and treatment of central nervous system disorders.
Salatin S; Farhoudi M; Sadigh-Eteghad S; Mahmoudi J
Expert Opin Drug Deliv; 2024 Apr; 21(4):521-535. PubMed ID: 38555483
[TBL] [Abstract][Full Text] [Related]
13. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanotheranostics for personalized cancer therapy.
Diou O; Tsapis N; Fattal E
Expert Opin Drug Deliv; 2012 Dec; 9(12):1475-87. PubMed ID: 23092183
[TBL] [Abstract][Full Text] [Related]
15. Theranostic applications of nanoparticles in neurodegenerative disorders.
Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
Dilnawaz F; Sahoo SK
Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
Jiang Y; Li Y; Liu X
Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
[TBL] [Abstract][Full Text] [Related]
18. Aggregation Induced Emission Fluorogens Based Nanotheranostics for Targeted and Imaging-Guided Chemo-Photothermal Combination Therapy.
Wang K; Fan X; Zhao L; Zhang X; Zhang X; Li Z; Yuan Q; Zhang Q; Huang Z; Xie W; Zhang Y; Wei Y
Small; 2016 Dec; 12(47):6568-6575. PubMed ID: 27555545
[TBL] [Abstract][Full Text] [Related]
19. Nanotheranostics for personalized medicine.
Mura S; Couvreur P
Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
[TBL] [Abstract][Full Text] [Related]
20. Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment.
Xue X; Huang Y; Bo R; Jia B; Wu H; Yuan Y; Wang Z; Ma Z; Jing D; Xu X; Yu W; Lin TY; Li Y
Nat Commun; 2018 Sep; 9(1):3653. PubMed ID: 30194413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
